Online Exclusives

The Visibility Trap: How to Keep Milestones Moving Without Guesswork

The fastest teams aren't the ones that ignore controls. They’re the ones who make control visible enough to keep work moving.

Author Image

By: Christine Pearsall

Director of Marketing, Enlil

Photo: Enlil

As presented in the first two installments of the series, When Milestones Become Fiction contributed by Enlil, a recurring industry pattern is clear: product development milestone issues rarely start as milestone issues.

In Part 1, “Engineering Speed vs. Manufacturing Risk: Why DHF Is Becoming Legacy”, we looked at how engineering speed can quietly turn into manufacturing risk when the prototype advances faster than the controlled record. A milestone may show progress, but if the evidence behind it points to the wrong revision, downstream teams inherit rework, supplier confusion, and transfer turbulence.

Next in Part 2, “Stop Running War Rooms by Building An Inspection-Ready Medical Device File Every Day“, we examined the other end of the same problem: the “War Room” scramble that happens when audit readiness is treated as a reaction instead of a routine. When records must be hunted down before an inspection, the issue is not simply disorganization. It is a sign that evidence has not been maintained as part of everyday execution.

This third and final article focuses on what often sits between those two failure modes: visibility.

A team can have strong engineers, capable quality leaders, diligent regulatory staff, and experienced manufacturing partners, and still miss critical signals if milestone readiness is managed through verbal updates, spreadsheets, and assumptions. A milestone can look on track while the evidence behind it is stalled in draft, waiting for approval, tied to the wrong revision, or scattered across systems.

That’s the visibility trap. The organization believes it’s managing the timeline, but it’s really managing assumptions.

For medical device OEMs and their contract partners, assumption-based milestone management is risky. It creates downstream disruption in transfer, manufacturing, supplier coordination, quality review, and submission preparation. More importantly, it hides problems until they’re expensive to fix.

The Problem with ‘I Think It’s Done’

Most teams have heard some version of the same status update:

“I think the report is done.”
“Engineering has it.”
“Quality is reviewing it.”
“We’re just waiting on one signature.”
“The supplier has the latest version…I believe.”

None of those statements are necessarily wrong. They’re simply not evidence.

When organizations rely on verbal updates or manually maintained spreadsheets to manage regulated milestones, they create a gap between activity and proof. A task may be underway, but that doesn’t mean the required record is complete. A record may be complete, but that doesn’t mean it’s approved. A document may be approved, but that doesn’t mean it reflects the current design state.

That distinction matters because regulated progress depends on the state of evidence, not effort.

In manufacturing terms, this is no different from releasing a build based on “the parts are probably available.” Operations teams would never accept that level of uncertainty for inventory, production, or supplier readiness. Yet many organizations accept it for design control milestones, where the downstream consequences can be just as disruptive.

Photo: Enlil

When Project Tracking Becomes False Confidence

Most project tools are excellent at showing dates, owners, and percent complete. But they often struggle to show whether the regulated evidence behind a milestone is truly complete, current, approved, and traceable.

That difference is where false confidence begins.

A project dashboard may show “Design Verification Complete” at 90 percent. But what does that mean operationally?

  • Are all protocols approved?
  • Are all reports finalized and linked to the correct requirements?
  • Do the reports reference the current design output revisions?
  • Have risk controls been updated based on test results?
  • Are deviations documented and closed?
  • Are approvers assigned, responsive, and accountable?
  • Can the evidence package be reproduced during an audit or submission review?

If the system cannot answer those questions quickly, the milestone really isn’t visible. It is being interpreted.

The Part 2 “War Rooms” article framed this issue around audit readiness: Organizations should be able to retrieve records, approval status, and change history within minutes, not after a search party forms around a shared drive. The same principle applies to milestone visibility. If the team cannot quickly see what’s missing, outdated, unapproved, or blocked, leadership is steering with a fogged windshield.

Visibility Must Extend Across Functions

Milestone visibility isn’t just a PMO problem. It’s a cross-functional operating requirement.

Engineering may own the design outputs. Quality may own approval workflows and audit readiness. Regulatory may own submission structure. Manufacturing owns transfer readiness and product build execution. Suppliers may depend on released specifications and acceptance criteria. When each function sees only its own slice, the full readiness picture becomes fragmented.

That fragmentation is where critical-path items get stuck.

A verification report may sit in draft because an approver is overloaded. A drawing revision may be released but not reflected in supplier documentation. A risk control may change without triggering a review of downstream verification evidence. A transfer milestone may appear green while training records, inspection criteria, or manufacturing instructions are incomplete.

Each issue may look small in isolation. Together, they create schedule risk.

Cross-functional visibility should answer four questions at any time:

  1. What evidence is required for this milestone?
  2. What is complete, approved, and current?
  3. What is missing, outdated, or blocked?
  4. Who owns the next action?

If those answers require three meetings and a spreadsheet archaeology expedition, the system isn’t providing visibility. It’s providing administrative smoke and mirrors.

The DHF-to-MDF Shift Raises the Bar

As discussed earlier in the series, the industry is moving away from treating the Design History File (DHF) as a static or late-stage compilation exercise. DHF remains a familiar legacy term, especially for U.S. teams navigating the QMSR transition, but the directional shift is toward lifecycle evidence discipline and a continuously maintained Medical Device File (MDF).

That shift increases the importance of real-time visibility. An MDF mindset requires that evidence remain coherent as the device evolves. Requirements, risks, design outputs, verification, validation, change records, manufacturing specifications, and post-market inputs must stay connected over time.

Without visibility, that lifecycle story breaks.

A team may be able to assemble a DHF-style package at the end of development, but a modern evidence model demands more. It must show how decisions were made, what changed, why it changed, what was impacted, and whether downstream evidence remained valid.

That’s difficult to prove if milestone status lives in one system, documents in another, risk files in another, and approvals in email.

What Good Milestone Visibility Looks Like

Good milestone visibility isn’t a prettier dashboard. It’s a more reliable operating model.

At a minimum, milestone visibility should include:

Evidence status. Each milestone should show which records are required, which are complete, which are approved, and which are missing or overdue.
Revision alignment. The team should be able to see whether milestone evidence reflects the current design state or whether newer revisions may have impacted previously completed work.
Approval bottlenecks. Draft and pending records shouldn’t disappear into the system. The assigned owner, approver, due date, and aging status should be visible.
Traceability coverage. Requirements, risks, tests, reports, and change records should connect cleanly enough that gaps can be identified before submission or audit preparation.
Snapshot history. When a milestone closes, the organization should preserve what was true at that point in time. This is critical when later changes occur, and teams need to explain what evidence supported a decision.

The goal isn’t surveillance; it’s coordination. People cannot resolve bottlenecks they cannot see.

A Practical Readiness Dashboard

For teams trying to improve visibility without launching a massive transformation project, start with one high-risk milestone. Verification complete and transfer-ready are strong candidates because mistakes at those points tend to create significant rework.

Build a simple readiness dashboard around that milestone with the following fields:

  • Milestone name and target date
  • Required evidence items
  • Record owner
  • Current approval state
  • Applicable revision
  • Linked requirement, risk, or test reference
  • Open change impacts
  • Due date
  • Overdue status
  • Blocker description
  • Next action owner

This approach turns status meetings into decision meetings. Better still, it reduces the number of meetings where everyone politely agrees to “circle back,” which is often corporate-speak for “nobody owns this yet.”

From Milestone Reporting to Milestone Control

The real opportunity is to move from milestone reporting to milestone control. Reporting tells leadership what people believe is happening. Control shows what the evidence proves is happening.

That distinction matters in high-growth medtech environments, where speed is essential but unmanaged speed creates rework. Teams don’t need slower development, they need clearer signals. They need to know when a milestone is truly ready, when a change has affected downstream evidence, and when a critical record is stuck before it becomes a schedule threat.

Several of these scenarios were discussed in the “Building FDA-Ready Milestones” webinar that Enlil co-presented with AVS Life Sciences, including the visibility trap that occurs when teams manage timelines in the dark. The practical lesson is straightforward: milestone visibility must be tied to evidence readiness, not just timeline status.

The Takeaway

Milestones shouldn’t depend on memory, verbal updates, or heroic follow-up. They should provide a shared, factual view of progress across functions.

When teams can see evidence status, ownership, revision alignment, approvals, and blockers in real time, they reduce surprises. They protect transfer timelines. They improve audit readiness. They give manufacturing and quality teams the clarity needed to execute without guesswork.

The fastest teams aren’t the ones that ignore controls. They’re the ones who make control visible enough to keep work moving.

That’s how milestones stop being fiction and start becoming a reliable operating system for growth.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters